Therefore, a comprehensive understanding of the abnormal expression of members of the JAK2/STAT3 signaling pathway and the effects on the classic EMT process and cancer stem cells provide new ideas for the development of methods to effectively inhibit the malignant progression of glioma. This evidence concerns the gene JAK2 and cancer.